FIELD: chemistry.
SUBSTANCE: invention concerns novel compound of crystalline polymorphous bisulfate form with antagonistic effect on thrombin receptors, displaying x-ray refraction in powder, almost identical to picture in Figure 1, or displaying differential scanning calorimetry diagram almost identical to picture in Figure 3, and presented by compound 2 formula: 
Compound 2. Additionally invention concerns method of obtaining compound 2.
EFFECT: claimed pharmaceutical composition including polymorphous bisulfate form and at least one solvent or carrier, and application of polymorphous form of compound 2 in treatment of various physiological disorders, such as thrombosis.
16 cl, 3 dwg, 3 tbl, 1 ex
| Title |
Year |
Author |
Number |
| CRYSTALLINE POLYMORPHOUS FORMS OF CXC CHEMOKINE RECEPTOR LIGANDS |
2005 |
- Khu Mengvej
- Ju Jounong
- Dvajer Majkl
- Tehverehs Artur Dzh.
- Kim-Mid Agnes
- Jin Dzhianguo
- Fu Ksiaojong
- Makalister Timoti
- Zhang Shuji
- Klopfer Kevin
|
RU2388756C2 |
| POLYMORPHOUS AND AMORPHOUS FORMS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINE[5,4,3-CD]INDOL-6-ON PHOSPHATE |
2005 |
- Liu Dzhia
- Najjar Naresh
- Guo Ming
- Vu Zhen-Ping
- Borer Bennett Shaplin
- Shrirangam Aparna Nadig
- Mitchell Mark Brajan
- Li Ji
- Chu Dzhan-Dzhon
|
RU2355691C2 |
| CRYSTALLINE FORMS OF KNOWN PYRROLIDINE INHIBITOR OF XA FACTOR |
2006 |
- Samas Brajan Mehtt'Ju
- Vriz Derek Klinton
|
RU2368610C2 |
| CRYSTALLINE IRINOTECAN HYDROCHLORIDE POLYMORPHOUS FORM, METHOD FOR ITS PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
2003 |
- Forino Romual'Do
- Barbudzhan Natale
- Dzamp'Eri Massimo
- Tomazi Attilio
|
RU2300535C2 |
| NOVEL CRYSTALLINE FORMS OF 4,4'-[4-FLUORO-7({4-[4-(3-FLUORO-2-METHYLPHENYL)BUTOXY]PHENYL} ETHYNYL)-2-METHYL-1H-INDOLE-1,3-DIIYL]DIBUTANOIC ACID, 4,4'-[2-METHYL-7-({4-[4-(PENTAFLUOROPHENYL)BUTOXY]PHENYL} ETHYNYL)-1H-INDOLE-1,3-DIIYL]DIBUTANOIC ACID AND 4,4'-[4-FLUORO-2-METHYL-7-({4-[4-(2,3,4,6-TETRAFLUOROPHENYL) BUTOXY]PHENYL} ETHYNYL)-1H-INDOLE-1,3-DIIYL]DIBUTANOIC ACID |
2011 |
- Takehuti Dzjun
- Itadani Satosi
- Uehda Dzjunja
- Ono Sidzuka
- Nehkado Takakhiro
- Fudzita Manabu
|
RU2560147C2 |
| C-MET/HGFR INHIBITOR POLYMORPHS |
2006 |
- Kui Dzhingrong Dzhin
- Trehn-D'Jub Mishel' Bich
|
RU2387650C2 |
| CRYSTALLINE FORM OF COMPOUND SUPPRESSING PROTEIN KINASE ACTIVITY AND THE USE THEREOF |
2017 |
- Lyan, Tsunsin
- Ma, Yunbin
- Khe, Vej
|
RU2744264C2 |
| NOVEL CRYSTALLINE FORMS OF SODIUM SALT OF (4-{4-[5-(6-TRIFLUOROMETHYL-PYRIDIN-3-YLAMINO)PYRIDIN-2-YL]PHENYL}CYCLOHEXYL) ACETIC ACID |
2011 |
|
RU2612556C2 |
| POLYCRYSTALLINE FORM OF FREE BASE OR ACID ADDITION SALT OF INHIBITOR EGFR, METHOD OF ITS PRODUCTION AND APPLICATION |
2016 |
- Chen Chzhunke
- Lyu Fupin
- Lyu Lej
- Bao Rudi
|
RU2733412C2 |
| TOSYLATE SALT OF THERAPEUTIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF |
2008 |
- Uehjger Trehvis T.
- Batler Todd Uill'Jam
|
RU2430099C2 |
